| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 9,865,000 | 9,406,000 | 9,484,000 | 9,011,000 | | Cost of Revenue | 8,380,000 | 8,096,000 | 8,177,000 | 7,586,000 | | | Gross Profit | 1,485,000 | 1,310,000 | 1,307,000 | 1,425,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 742,000 | 1,023,000 | 950,000 | 786,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 743,000 | 287,000 | 357,000 | 639,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (252,000) | 117,000 | (69,000) | (136,000) | | Earnings Before Interest And Taxes | 576,000 | 387,000 | 305,000 | 592,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 576,000 | 387,000 | 305,000 | 592,000 | | Income Tax Expense | 121,000 | 81,000 | 64,000 | 124,000 | | Minority Interest | (16,000) | (17,000) | (6,000) | 1,000 | | | | Net Income From Continuing Ops | 439,000 | 289,000 | 235,000 | 469,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (3,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 439,000 | 289,000 | 235,000 | 466,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $439,000 | $289,000 | $235,000 | $466,000 |
|
3.31% Nasdaq 
Income Statement
